Analytical Data
-
Gene name
CCDC103
- Application
-
Alternative Names
CCDC103Coiled-coil domain-containing Protein 103
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IW40
-
Expression Region
1-242aa
-
AA Sequence
MERNDIINFKALEKELQAALTADEKYKRENAAKLRAVEQRVASYEEFRGIVLASHLKPLERKDKMGGKRTVPWNCHTIQGRTFQDVATEISPEKAPLQPETSADFYRDWRRHLPSGPERYQALLQLGGPRLGCLFQTDVGFGLLGELLVALADHVGPADRAAVLGILCSLASTGRFTLNLSLLSRAERESCKGLFQKLQAMGNPRSVKEGLSWEEQGLEEQSGGLQEEERLLQELLELYQVD
-
Molecular Weight
53.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCDC106, or Coiled-Coil Domain Containing 106, has emerged as a protein of interest in the context of cellular biology and disease research. Initially identified for its coiled-coil structural motifs, which are indicative of protein-protein interactions, CCDC106 is thought to play significant roles in various cellular processes, including cell signaling, cytoskeletal organization, and potentially in the pathogenesis of certain diseases. Recent studies have suggested that dysregulation of CCDC106 may be linked to cancer and neurodegenerative diseases, sparking interest in understanding its functional mechanisms. The production of recombinant CCDC106 protein is crucial for elucidating its biological roles and interactions at the molecular level. By employing techniques such as recombinant DNA technology, researchers can generate this protein in heterologous systems, facilitating detailed biochemical analyses, structural studies, and the exploration of its potential as a therapeutic target. The continued investigation into CCDC106 not only aims to clarify its contributions to cellular function but also to uncover its implications in disease states, thereby broadening our understanding of its significance in both health and pathology.
